← All stocks

aTYR PHARMA INC

ATYR No buying or selling
CIK 0001339970 #4704 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SCHIMMEL PAUL
Director
779,143
$386.69K
Shukla Sanjay
President and CEO
153,553
$76.21K
+12.5%
Broadfoot Jill Marie
Chief Financial Officer
37,296
$18.51K
+14.4%
DENYES NANCY
General Counsel
33,124
$16.44K
+11.3%
Gross Jane A
Director
9,750
$4.84K
+62.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 15 Sep 2016